vs
Side-by-side financial comparison of Electromed, Inc. (ELMD) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.
WEST BANCORPORATION INC is the larger business by last-quarter revenue ($26.9M vs $18.9M, roughly 1.4× Electromed, Inc.). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs 14.6%, a 24.6% gap on every dollar of revenue. On growth, WEST BANCORPORATION INC posted the faster year-over-year revenue change (16.6% vs 16.3%). WEST BANCORPORATION INC produced more free cash flow last quarter ($12.4M vs $2.4M). Over the past eight quarters, WEST BANCORPORATION INC's revenue compounded faster (17.3% CAGR vs 16.7%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.
ELMD vs WTBA — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.9M | $26.9M |
| Net Profit | $2.8M | $10.6M |
| Gross Margin | 78.4% | — |
| Operating Margin | 19.2% | 50.0% |
| Net Margin | 14.6% | 39.2% |
| Revenue YoY | 16.3% | 16.6% |
| Net Profit YoY | 40.3% | 34.8% |
| EPS (diluted) | $0.32 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $26.9M | ||
| Q4 25 | $18.9M | $24.2M | ||
| Q3 25 | $16.9M | $25.0M | ||
| Q2 25 | $17.4M | $23.8M | ||
| Q1 25 | $15.7M | $23.1M | ||
| Q4 24 | $16.3M | $20.9M | ||
| Q3 24 | $14.7M | $20.3M | ||
| Q2 24 | $14.8M | $19.6M |
| Q1 26 | — | $10.6M | ||
| Q4 25 | $2.8M | $7.4M | ||
| Q3 25 | $2.1M | $9.3M | ||
| Q2 25 | $2.2M | $8.0M | ||
| Q1 25 | $1.9M | $7.8M | ||
| Q4 24 | $2.0M | $7.1M | ||
| Q3 24 | $1.5M | $6.0M | ||
| Q2 24 | $1.8M | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | 78.4% | — | ||
| Q3 25 | 78.1% | — | ||
| Q2 25 | 78.3% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 77.7% | — | ||
| Q3 24 | 78.3% | — | ||
| Q2 24 | 76.2% | — |
| Q1 26 | — | 50.0% | ||
| Q4 25 | 19.2% | 39.6% | ||
| Q3 25 | 15.8% | 45.8% | ||
| Q2 25 | 17.5% | 43.4% | ||
| Q1 25 | 13.6% | 43.4% | ||
| Q4 24 | 15.6% | 30.9% | ||
| Q3 24 | 13.2% | 36.6% | ||
| Q2 24 | 15.7% | 32.6% |
| Q1 26 | — | 39.2% | ||
| Q4 25 | 14.6% | 30.7% | ||
| Q3 25 | 12.6% | 37.3% | ||
| Q2 25 | 12.7% | 33.5% | ||
| Q1 25 | 12.1% | 34.0% | ||
| Q4 24 | 12.1% | 34.0% | ||
| Q3 24 | 10.0% | 29.3% | ||
| Q2 24 | 12.3% | 26.5% |
| Q1 26 | — | $0.61 | ||
| Q4 25 | $0.32 | $0.44 | ||
| Q3 25 | $0.25 | $0.55 | ||
| Q2 25 | $0.26 | $0.47 | ||
| Q1 25 | $0.21 | $0.46 | ||
| Q4 24 | $0.22 | $0.41 | ||
| Q3 24 | $0.16 | $0.35 | ||
| Q2 24 | $0.20 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.8M | $362.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.4M | $270.7M |
| Total Assets | $54.9M | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $362.0M | ||
| Q4 25 | $13.8M | $471.1M | ||
| Q3 25 | $14.1M | $232.9M | ||
| Q2 25 | $15.3M | $345.2M | ||
| Q1 25 | $15.2M | — | ||
| Q4 24 | $16.2M | $243.5M | ||
| Q3 24 | $13.9M | — | ||
| Q2 24 | $16.1M | — |
| Q1 26 | — | $270.7M | ||
| Q4 25 | $45.4M | $266.0M | ||
| Q3 25 | $44.7M | $255.1M | ||
| Q2 25 | $43.2M | $240.9M | ||
| Q1 25 | $43.9M | $237.9M | ||
| Q4 24 | $43.6M | $227.9M | ||
| Q3 24 | $41.5M | $235.4M | ||
| Q2 24 | $44.5M | $223.9M |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $54.9M | $4.1B | ||
| Q3 25 | $53.6M | $4.0B | ||
| Q2 25 | $53.8M | $4.1B | ||
| Q1 25 | $52.5M | $4.0B | ||
| Q4 24 | $52.3M | $4.0B | ||
| Q3 24 | $48.9M | $4.0B | ||
| Q2 24 | $52.2M | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $12.9M |
| Free Cash FlowOCF − Capex | $2.4M | $12.4M |
| FCF MarginFCF / Revenue | 12.7% | 46.0% |
| Capex IntensityCapex / Revenue | 3.4% | 1.8% |
| Cash ConversionOCF / Net Profit | 1.10× | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | $7.9M | $79.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $12.9M | ||
| Q4 25 | $3.0M | $46.5M | ||
| Q3 25 | $169.0K | $11.4M | ||
| Q2 25 | $3.9M | $13.5M | ||
| Q1 25 | $2.1M | $9.7M | ||
| Q4 24 | $3.2M | $39.8M | ||
| Q3 24 | $2.3M | $12.9M | ||
| Q2 24 | $4.5M | $10.0M |
| Q1 26 | — | $12.4M | ||
| Q4 25 | $2.4M | $43.2M | ||
| Q3 25 | $-83.0K | $10.8M | ||
| Q2 25 | $3.7M | $12.8M | ||
| Q1 25 | $1.9M | $8.3M | ||
| Q4 24 | $2.9M | $13.7M | ||
| Q3 24 | $2.3M | $7.0M | ||
| Q2 24 | $4.5M | $2.7M |
| Q1 26 | — | 46.0% | ||
| Q4 25 | 12.7% | 178.3% | ||
| Q3 25 | -0.5% | 43.0% | ||
| Q2 25 | 21.4% | 53.6% | ||
| Q1 25 | 12.2% | 35.7% | ||
| Q4 24 | 18.0% | 65.6% | ||
| Q3 24 | 15.5% | 34.2% | ||
| Q2 24 | 30.1% | 14.0% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 3.4% | 13.7% | ||
| Q3 25 | 1.5% | 2.6% | ||
| Q2 25 | 0.8% | 3.2% | ||
| Q1 25 | 1.0% | 6.5% | ||
| Q4 24 | 1.4% | 125.3% | ||
| Q3 24 | 0.3% | 29.4% | ||
| Q2 24 | 0.1% | 37.1% |
| Q1 26 | — | 1.22× | ||
| Q4 25 | 1.10× | 6.26× | ||
| Q3 25 | 0.08× | 1.23× | ||
| Q2 25 | 1.75× | 1.70× | ||
| Q1 25 | 1.10× | 1.24× | ||
| Q4 24 | 1.60× | 5.61× | ||
| Q3 24 | 1.57× | 2.17× | ||
| Q2 24 | 2.46× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
WTBA
Segment breakdown not available.
